Amphastar Pharmaceuticals, Inc. News Releases http://ir.amphastar.com/ Amphastar Pharmaceuticals, Inc. News Releases en Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference http://ir.amphastar.com/news-releases/news-release-details/amphastar-pharmaceuticals-present-bmo-prescriptions-success RANCHO CUCAMONGA, Calif. , June 24, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell , President, will be presenting at the BMO Prescriptions for Success Healthcare Conference on Tuesday, June 25, 2019 at 2:40 p.m. Mon, 24 Jun 2019 06:00:00 -0400 Amphastar Pharmaceuticals, Inc. News Releases 9406 Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz http://ir.amphastar.com/news-releases/news-release-details/amphastar-pharmaceuticals-inc-announces-settlement-litigation RANCHO CUCAMONGA, Calif. , June 19, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. , (NASDAQ: AMPH) today announced that it has entered into a settlement agreement (the “Settlement Agreement”) with Momenta Pharmaceuticals Inc. and Sandoz Inc. , (collectively, “Momenta/Sandoz”). Wed, 19 Jun 2019 06:00:00 -0400 Amphastar Pharmaceuticals, Inc. News Releases 9396 Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference http://ir.amphastar.com/news-releases/news-release-details/amphastar-pharmaceuticals-present-raymond-james-life-sciences RANCHO CUCAMONGA, Calif. , June 14, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters , CFO, will be presenting at the Raymond James Life Sciences and MedTech Healthcare Conference on Wednesday, June 19, 2019 at 4:10 p.m. Fri, 14 Jun 2019 06:00:00 -0400 Amphastar Pharmaceuticals, Inc. News Releases 9376 Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference http://ir.amphastar.com/news-releases/news-release-details/amphastar-pharmaceuticals-present-jefferies-2019-healthcare RANCHO CUCAMONGA, Calif. , May 31, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell , President and Bill Peters , CFO, will be presenting at the Jefferies 2019 Healthcare Conference on Wednesday, June 5, 2019 at 8:30 a.m. Fri, 31 May 2019 06:00:00 -0400 Amphastar Pharmaceuticals, Inc. News Releases 9306 Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019 http://ir.amphastar.com/news-releases/news-release-details/amphastar-pharmaceuticals-present-bank-america-merrill-lynch-1 RANCHO CUCAMONGA, Calif. , May 10, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell , President and Bill Peters , CFO, will be presenting at the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, 2019 at 3:40 p.m. Fri, 10 May 2019 06:00:00 -0400 Amphastar Pharmaceuticals, Inc. News Releases 9281 Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019 http://ir.amphastar.com/news-releases/news-release-details/amphastar-pharmaceuticals-reports-financial-results-three-10 Reports Net Revenues of $79.8 Million for the Three Months Ended March 31, 2019 RANCHO CUCAMONGA, Calif. , May 09, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended March 31, 2019 . Thu, 09 May 2019 16:05:00 -0400 Amphastar Pharmaceuticals, Inc. News Releases 9271 Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2019 http://ir.amphastar.com/news-releases/news-release-details/amphastar-pharmaceuticals-release-first-quarter-earnings-and-3 RANCHO CUCAMONGA, Calif. , May 06, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its first quarter of 2019 ended March 31, 2019 , after the market closes on Thursday, May 9, 2019 , and will hold a conference call to Mon, 06 May 2019 06:00:00 -0400 Amphastar Pharmaceuticals, Inc. News Releases 9256 Amphastar Pharmaceuticals Receives FDA Approval for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Dose Vial http://ir.amphastar.com/news-releases/news-release-details/amphastar-pharmaceuticals-receives-fda-approval-enoxaparin RANCHO CUCAMONGA, Calif. , March 19, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. , (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration ( FDA ) granted approval of its Abbreviated New Drug Application (“ANDA”) for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Tue, 19 Mar 2019 06:00:00 -0400 Amphastar Pharmaceuticals, Inc. News Releases 9191 Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2018 http://ir.amphastar.com/news-releases/news-release-details/amphastar-pharmaceuticals-reports-financial-results-three-9 Reports Net Revenues of $89.7 Million for the Three Months Ended December 31, 2018 RANCHO CUCAMONGA, Calif. , March 12, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months and full year ended December 31, Tue, 12 Mar 2019 16:05:00 -0400 Amphastar Pharmaceuticals, Inc. News Releases 9146 Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2019 http://ir.amphastar.com/news-releases/news-release-details/amphastar-pharmaceuticals-release-fourth-quarter-earnings-and-3 RANCHO CUCAMONGA, Calif. , March 07, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its fourth quarter of 2018 ended December 31, 2018 , after the market closes on Tuesday, March 12, 2019 , and will hold a conference call Thu, 07 Mar 2019 16:01:00 -0500 Amphastar Pharmaceuticals, Inc. News Releases 9136